Relx PLC (LON:REL)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1,875.42 and traded as high as $1,881.74. Relx shares last traded at $1,845.00, with a volume of 2,393,794 shares traded.
Several research analysts recently weighed in on REL shares. Goldman Sachs Group increased their price objective on Relx from GBX 2,178 ($28.46) to GBX 2,378 ($31.07) and gave the stock a “buy” rating in a research report on Monday, October 28th. UBS Group reiterated a “sell” rating on shares of Relx in a research report on Friday, October 25th. Liberum Capital reiterated a “buy” rating and issued a GBX 1,750 ($22.87) price objective on shares of Relx in a research report on Thursday, October 24th. Barclays reiterated an “overweight” rating and issued a GBX 2,090 ($27.31) price objective on shares of Relx in a research report on Friday, October 25th. Finally, JPMorgan Chase & Co. increased their price objective on Relx from GBX 1,900 ($24.83) to GBX 1,950 ($25.48) and gave the stock an “overweight” rating in a research report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of GBX 1,891.92 ($24.72).
The company has a debt-to-equity ratio of 308.02, a current ratio of 0.45 and a quick ratio of 0.40. The business has a 50 day simple moving average of GBX 1,834.73 and a 200 day simple moving average of GBX 1,876.17. The company has a market capitalization of $36.29 billion and a price-to-earnings ratio of 23.92.
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
See Also: Why is total return important?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.